Toll-like receptor-4 modulation for cancer immunotherapy.

Toll-like receptor-4 modulation for cancer immunotherapy.

Item
http://www.wikidata.org/entity/Q38239659
Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4.Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitroThe TLR4-Active Morphine Metabolite Morphine-3-Glucuronide Does Not Elicit Macrophage Classical Activation In Vitro.TLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide instructed primary tumor outgrowth in lung cancer patients.Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin.Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.Pharmacological TLR4 antagonism using topical resatorvid blocks solar UV-induced skin tumorigenesis in SKH-1 mice.Activation of viral defense signaling in cancer
P2860

Toll-like receptor-4 modulation for cancer immunotherapy.

Item
http://www.wikidata.org/entity/Q38239659
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Toll-like receptor-4 modulation for cancer immunotherapy.
@en
type
label
Toll-like receptor-4 modulation for cancer immunotherapy.
@en
prefLabel
Toll-like receptor-4 modulation for cancer immunotherapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Toll-like receptor-4 modulation for cancer immunotherapy.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932